Japan’s MHLW accepts for review GSK’s NDA for Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Wednesday, September 18, 2024, 10:00 Hrs [IST] GSK plc a ...
China’s NMPA granted BTD for Blenrep (belantamab mafodotin) combined with BorDex for the treatment of multiple myeloma.
GSK’s Blenrep in combo with BorDex receives China NMPA breakthrough therapy designation to treat relapsed/refractory multiple myeloma: London, UK Saturday, September 14, 2024, 0 ...
Certain genetic changes, or mutations, can increase the chances of leukemia or blood cancer. According to experts, leukemia, ...
During a Case-Based Roundtable® event, Andrzej Jakubowiak, MD, PhD, discussed 2 recent trials in multiple myeloma for ...
Undetectable measurable residual disease rates can help predict progression-free survival in patients with chronic ...
NEW YORK, NY - JUNE 10: Bruce Springsteen and Patti Scialfa attend the 72nd Annual Tony Awards at ... [+] Radio City Music Hall on June 10, 2018 in New York City. (Photo by Jemal Countess/Getty ...
A father-of-two was left '2mm from paralysis' after his neck snapped and he ignored warning signs of a rare blood cancer, writing them off as signs of ageing. Simon Cummings, 53, first noticed a ...